Chiltern Opens New Office in Argentina

LONDON, February 17, 2010 – Chiltern International Limited (Chiltern), a global clinical contract
research organization (CRO) announced that it has opened a new office in
Argentina.

Oscar Podest??, Chiltern Executive Director, Latin America, leads this
endeavor. "Our office, strategically located in suburban Pilar, is a natural
next step to our development in Argentina. The office's [...]

Pipeline/Commercial Insight: Supportive Care in Oncology – Innovation and Market Growth Limited to Bone Metastases Management and Emerging Supportive Care Challenges Reports Now Available on ReportsandReports

ReportsandReports announce to have Pipeline/Commercial Insight: Supportive Care in Oncology – Innovation and market growth limited to bone metastases management and emerging supportive care challenges ( https://www.reportsandreports.com/market-reports/pipeline-commercial-insight-s upportive-care-in-oncology-innova/) Market Research Report in its store

DALLAS, February 16, 2010 – (Due to the length of this URL, it may be necessary to copy and paste
this hyperlink [...]

Rising Popularity of Home Care Underlines Rise of Care Management Markets Across Europe, Finds Frost & Sullivan

LONDON, February 16, 2010 – Europe's patient population is moving towards long-term care and homecare
from hospitals and other clinical settings. Consequently, the significance of
nursing and residential care services is on the rise. Unlike the past decade,
therefore, the number of care homes in Europe has shown an increase. At the
same time, care managers have been [...]

IPA Helps Researchers Utilize and Share Current Disease Knowledge Through New Dynamic Reporting Capability

REDWOOD CITY, California, February 16 – Ingenuity(R) Systems, the leading provider of information solutions for
life science researchers, today announced the addition of dynamic reports,
new weekly content updates, and metabolomics workflow support in the latest
release of IPA(R) software.

Life science researchers need to keep up with increasingly complex
developments in the diagnosis, treatment, [...]

Oncolytics Biotech(R) Inc. Receives Approval from the U.K. MHRA to Conduct Phase 3 Trial for REOLYSIN(R) in Head and Neck Cancers

Company to Host Clinical Update Conference Call
CALGARY, Canada, February 16, 2010 – Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today
announced that it has received a letter of approval from the U.K. Medicines
and Healthcare products Regulatory Agency (MHRA) to conduct its Phase 3 trial
examining REOLYSIN in combination with paclitaxel and carboplatin in patients
with platinum-refractory head and [...]

EU Recognizes Importance of ASI’s Research on Developing New Smart Imaging Molecular Tools for Combating Neurodegenerative Diseases

The European Union's Seventh Framework Program (FP7) Research on the Brain and Related Diseases Funding the Framework Program for Research and Technological Development (RTD)

MIGDAL HAEMEK, Israel, February 16, 2010 – Neurodegenerative diseases such as Alzheimer's set a challenge
for modern medicine, as their origins are unclear and the comprehension of
the progression of symptoms often relies [...]

MEDai and Shared Health(R) Partner to Offer Tennessee Robust Health Information Exchange Platform

ORLANDO, Florida, February 16, 2010 – Shared Health, Inc., Tennessee's largest public/private health
information exchange (HIE) has partnered with MEDai, an Elsevier company, to
provide a rich, interoperable, clinically relevant HIE platform to the state
of Tennessee. This partnership delivers best in class solutions and
technologies that support clinical excellence and operating efficiencies. It
comes at a time when [...]

Mount Vernon Cancer Centre Becomes First NHS Facility to Acquire a CyberKnife System

Government Purchase Enhances Patient Access to Whole Body Radiosurgery
SUNNYVALE, California, February 15, 2010 – Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of
radiosurgery, announced today that Mount Vernon Cancer Centre in the United
Kingdom has become the first National Health Service (NHS) hospital to
acquire a CyberKnife(R) Robotic Radiosurgery System.

The [...]

Dutch Public-Private Partnership Invests 28 Million Euro on Research Into Personalized Medicine

GELEEN-EINDHOVEN-LEIDEN, The Netherlands, February 15, 2010 – The Netherlands' three Top Institutes for life-science research (the
BioMedical Materials program, the Center for Translational Molecular Medicine
and Top Institute Pharma) today announced a joint investment of MEUR 28 on
innovative research targeted at bringing personalized medicine closer to
reality. The projects funded by the group will focus on developing [...]

Chocolate Industry Leaders Sign Agreement, Align on Path Towards Increasing Consumer Availability & Consistency of Beneficial Cocoa Flavanols

Cooperation expected to yield a standard for active natural cocoa compounds
MCLEAN, Virginia and ZURICH, February 15, 2010 – The unique and good-for-you cocoa flavanols – the natural compounds found
in the cocoa fruit linked to important circulatory and other health benefits
- will soon be easier to identify and obtain when making nutrition choices.
Mars, Incorporated and [...]

25th International Conference of Alzheimer’s Disease International March 10-13, 2010 – Thessaloniki, Greece

LONDON, February 12 – SAVE THE DATE and REGISTER NOW for the 25th International Conference of
Alzheimer's Disease International (ADI). The theme is "Dementia: Making A
Difference." The location is the Grand Hotel Palace, 305-307 Monastiriou
Str., Thessaloniki, Greece.

"We welcome you to create connections, share experiences, gather
knowledge and make a difference to the [...]

De La Rue to Provide East Africa’s First eID Project

LONDON, February 11 – De La Rue Identity Systems, a world expert in secure e-government
identity solutions, today announced that it will design and roll-out East
Africa's first national eID project for the Government of Rwanda, as part of
the ongoing Rwandan National ID project (NID). The plans for systems
integration, to combine data from the current ID [...]

Elsevier is Meeting Today’s Medical Students’ Needs With Online, Mobile and Print Tools

Company Celebrates Medical Education Innovation at AMSA's 60th Anniversary Convention

PHILADEPHIA, February 22, 2010 – Elsevier, the leading publisher of scientific, technical and medical
information, today announced it is celebrating medical education innovation
at the American Medical Student Association's (AMSA) 60th Annual Convention
(www.amsa.org/AMSA/Homepage/Events/Convention.aspx), March 11-14,
2010, at the Disneyland Hotel in Anaheim, California.
"Elsevier is [...]

Retacrit(TM) to be the 1st Biosimilar Epoetin to Achieve Subcutaneous Licence in Renal Patients

Retacrit(TM) Received a Positive Opinion From the European Committee for Medicinal Products for Human Use (CHMP) for Subcutaneous (SC) use in Renal Anaemia

LONDON, February 22, 2010 – Hospira announced today that the European Committee for Medicinal
Products for Human Use (CHMP) has recommended for approval the administration
of Retacrit (epoetin zeta) subcutaneously in the nephrology setting. [...]

ConvaTec Introduces Flexi-Seal(R)(TM) SIGNAL(TM) FMS

A new solution from the Flexi-Seal(R)(TM) FMS family of fecal management systems that helps clinicians seal their patients' protection

SKILLMAN, New Jersey, February 22, 2010 – ConvaTec, a world-leading developer and marketer of innovative medical
technologies for community and hospital care, announced today the launch of
Flexi-Seal(R)(TM) SIGNAL(TM) Fecal Management System (FMS). Now available in
the U.S., U.K. [...]

Newton Gets 2 Years for World-First hGH Positive Finding

LONDON, February 22, 2010 – In a major breakthrough in the international fight against doping in
sport, UK Anti-Doping today announced the first case of human growth hormone
(hGH)* resulting in an athlete sanction.

Wakefield Trinity Wildcats player Terry Newton has accepted a 2-year
sanction for the presence of hGH in a blood sample [...]

Chiltern Announces Partnership With Charles River

LONDON, February 22, 2010 – Chiltern International Limited, a global contract research organization
(CRO), announced its latest collaboration with Charles River Laboratories,
Inc. As part of this collaboration, Chiltern Early Phase will partner with
Charles River to conduct and support early phase radiolabelled studies.

Glenn Kerkhof, Chiltern CEO, stated, "This new partnership is an [...]

Torchmark Corporation to Present at Bank of America Merrill Lynch Insurance Conference

MCKINNEY, Texas, February 22, 2010 – Torchmark Corporation (NYSE: TMK) announced today that its Chief
Executive Officer, Mark McAndrew, and Chief Financial Officer, Gary Coleman,
will present Tuesday, February 23, 2010 at the Bank of America Merrill Lynch
Insurance Conference in New York City. Torchmark's presentation is scheduled
to begin at 8:35 a.m. EST.

[...]

Amsterdam Molecular Therapeutics Reports Full Year Results 2009

AMSTERDAM, The Netherlands, February 24, 2010 – Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in
the field of human gene therapy, today reported its results for the year to
December 31, 2009.

Highlights
– Glybera(R) Marketing Authorisation Application submitted to
European Medicines Agency (EMA, formerly [...]

InteractElsevier Delivers 3-D Interactive Anatomy Learning Tools

Students, Researchers can 'Walk Through' a Body; Virtual Reality Meets Anatomy, as Advanced Gaming Technology Brings Human Body to Life

PHILADELPHIA, February 23, 2010 – Elsevier, the world's leading content provider of science and
health information, today announced the availability of the InteractElsevier
(www.interactelsevier.com) Series. Powered by CyberAnatomy, an
Iowa-based company that creates interactive learning systems for students,
the [...]

Elsevier’s new Custom Publication Guidelines set new Standards for Publishing Pharma-Sponsored Content

PHILADEPLHIA, Pennsylvania, February 23, 2010 – Elsevier, the world's leading publisher of scientific, technical and
medical (STM) information products and services announced today that it is
publicly sharing its internal custom publication guidelines so that the
scientific and medical communities can have insight into a new and practical
set of publishing standards for producing custom and sponsored publications.
The [...]

Charity SOS Children calls for “no UK deductions for Haiti”

CAMBRIDGE, England, February 23, 2010 – Orphan charity SOS Children UK is calling on all British NGOs
to pledge to make no UK deductions for Haiti – specifically to promise not to
use any donations or sponsorships given for Haiti in 2010 to pay for UK spend
on advertising, fundraising, admin, advocacy or anything else.

[...]

Ketchum and TBWA\RAAD\PR Create Joint Venture in Middle East; Firm Will be Known as Ketchum Raad Middle East

Two Premier Communications Networks Formalize Partnership, Combining Excellent Regional and Global Services and Capabilities

NEW YORK and DUBAI, February 23, 2010 – Ketchum, one of the world's leading public relations agencies, and
TBWA\RAAD\PR, the fast-growing communications network in the Middle East,
today announced the formation of a joint venture agreement to deliver
enhanced capabilities to clients in the [...]

International Rare Disease Day

"Patients and Researchers: Partners for Life!"
PARIS, February 24, 2010 – For this annual event hundreds of patient groups and their
partners organise activities to raise awareness on rare diseases and the 30
million people affected by them in Europe.

Rare Disease Day was launched and is coordinated by the
European Organisation for Rare Diseases [...]

Shire Provides Update on Biologics License Application (BLA) Filing for REPLAGAL(R) (agalsidase alfa) With the U.S. Food and Drug Administration (FDA)

CAMBRIDGE, Massachusetts, February 24, 2010 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty
biopharmaceutical company, announces it has received Fast Track designation
from the FDA for REPLAGAL(R) (agalsidase alfa), its enzyme replacement
therapy for Fabry disease.

Shire filed a BLA for REPLAGAL in December 2009. The FDA requested
additional human pharmacokinetic data to [...]

First Awards Made by London Genetics’ Proof-of-Concept Fund

LONDON, February 24, 2010 – London Genetics Limited, an expert in the use of pharmacogenetics in
clinical drug discovery and development, has awarded the first three grants
from its proof-of-concept (POC) fund. The awards, to teams at Imperial
College London and University College London, are for research in the areas
of immunotherapy, schizophrenia and heart disease. Financial details [...]

Sanmina-SCI Tatabanya, Hungary Facility Achieves ISO 13485 Certification for Medical Devices

SAN JOSE, California, February 24, 2010 – Sanmina-SCI Corporation (Nasdaq: SANM), a leading global Electronics
Manufacturing Services (EMS) company, today announced that its Tatabanya,
Hungary facility has received ISO 13485 certification for medical device
manufacturing.

ISO 13485 is an internationally recognized standard developed to ensure
that companies provide medical devices that consistently meet regulatory
requirements. In [...]

IPO Prospects High on the Agenda at BioTrinity

Venue: Newbury Racecourse From Apr 12-14 2010
LONDON, February 24, 2010 – First Quarter of 2010 has shown some early signs of resurgence in life
science IPO's that are already underway or planned. BioTrinity, the UK's
Premier Biopartnering and Investment Conference, will be focusing on the
evidence for early success and the prospects for the remainder of the [...]

Star Scientific Files Application with FDA for Ariva-BDL(TM) Approval as First Modified Risk Tobacco Product

GLEN ALLEN, Virginia, February 24, 2010 – Star Scientific, Inc. (Nasdaq: CIGX) announced that on Friday, February
19 the company filed an application with the Food & Drug Administration for
approval to market Ariva-BDL(TM) as a "modified risk" tobacco product under
the Family Smoking Prevention and Tobacco Control Act of 2009. This
submission is the first such application [...]

Princess Haya Calls for Action to Protect Health in the Developing World

GENEVA, February 24, 2010 – Tobacco use encouraged by aggressive marketing and growing obesity linked
to poor diets and physical inactivity endanger millions of people in the
developing world, Princess Haya Al Hussein of Jordan said today at a
conference hosted by the World Health Organization (WHO).

In a keynote address at the Noncommunicable [...]

Next Generation Ultrasound: An Evolution in Diagnosis and Therapy – Upcoming Frost & Sullivan Web Conference

LONDON, February 25, 2010 – Exposure to radiation from imaging equipment is constantly subjected to
scrutiny from regulatory authorities. Ultrasound poses no radiation threat
and is constantly further developed to accentuate primary and secondary
diagnosis. The next wave in ultrasound technology will witness advancements
in Elastography and Contrast Enhanced Ultrasound (CEUS) for diagnosis. High
intensity focused ultrasound (HIFU) is [...]

Champagne Louis Roederer Gets ‘Loved Up’ at the Love Ball in Aid of The Naked Heart Foundation

LONDON, February 25, 2010 – Champagne Louis Roederer were delighted to sponsor the Love
Ball on Tuesday night at The Roundhouse, Camden. The event, hosted by
Supermodel Natalia Vodianova and Lucy Yeomans, Editor of Harper's Bazaar UK,
also included an auction to raise funds for The Naked Heart Foundation, a
charity that builds play facilities for underprivileged children [...]

OBN Launches Unique Group Private Medical Insurance Scheme for Life Sciences Companies

OXFORD, England, February 25, 2010 – Oxfordshire Bioscience Network Ltd ("OBN"), the Oxford based
not-for-profit biotech trade association is pleased to announce that they
have secured a deal with BUPA which will allow the employees of their member
companies to receive highly competitive private medical insurance (PMI)
within a unique group scheme. The deal comes about as a [...]

Seatrans AS Increases Safeguards for Crew Members

Concateno Selected to Support Crew Welfare With New Benzene Monitoring Test
BERGEN, Norway and LONDON, February 25, 2010 – Concateno, Europe's most experienced chemical, drug and
alcohol testing provider with 20 years' experience in the maritime industry,
has been selected by Norwegian shipping company, Seatrans AS, to monitor the
potential exposure of its seafaring crew to benzene.

[...]

DPP Issues New Guidance on Assisted Suicide

LONDON, February 25, 2010 – The Director of Public Prosecutions (DPP) has launched new
guidance today on assisted suicide.

Their publication follows a successful campaign led by Debbie
Purdy, who has MS, on the issue of clarification around assisted suicide.
Jayne Spink, Director of Policy & Research at the MS [...]

WORLD PISTACHIO DAY: A Global Chance to Celebrate the Wonderful Green Nut

LOS ANGELES, February 25, 2010 – February 26th is World Pistachio Day, so why not take a moment to reflect
on the amazing history and modern day health benefits of this wonderful nut?

Pistachios contain only 3-4 calories per nut, and offer more than 30
different vitamins, minerals and beneficial phytonutrients making them [...]